Where does andrew talk about bpc-157?
Sources:
Andrew Huberman discusses BPC-157 in several clips from his podcast. Here are key insights from those discussions:
-
Anecdotal Evidence and Mechanism: BPC-157 is noted for its potential to enhance tissue recovery and angiogenesis (blood vessel growth) based on animal studies, but human clinical data is limited. He emphasizes its increasing use and the anecdotal reports suggesting beneficial effects, although caution is warranted due to the lack of rigorous human studies 1.
-
Injection Methods: Huberman explains that both systemic and local injections of BPC-157 can stimulate recovery; however, local injections might yield more significant immediate effects in specific injury sites. There is a notable concern about its implications for tumor growth as BPC-157 can promote vascularization, which is critical for tumors as well 2.
-
Growth Factors: He discusses how BPC-157 may help with wound healing by upregulating growth hormone receptors at injury sites, thereby potentially accelerating recovery. However, he warns that increasing these receptors around tumors could inadvertently facilitate their growth 3.
-
Safety Profile: Huberman points out that BPC-157 has a high safety profile with an extremely high lethal dose observed in animal studies. Typical recommended doses are 300-500 micrograms administered a few times weekly, but he advises caution against indiscriminate or continuous use without health monitoring 4.
-
Caution on Tumor Risks: Stressing the need for caution, he highlights that the same mechanisms that help in recovery may also contribute to tumorigenesis. Users should consider potential risks seriously, especially if they have existing health concerns 4.
You can find more in-depth insights and discussions about BPC-157 in these clips within the following episodes:
RELATED QUESTIONS-
